Extrapyramidal signs (EPSs) are commonly observed in patients with Alzheimer disease (AD). We report here the base rate of EPS in a large cohort of patients with AD who were not receiving neuroleptic drugs, and the associations of EPS with functional outcomes and depressive symptoms.
Methods:
In a consortium involving 56 clinics, we recruited 2614 patients with AD. We estimated basic activities of daily living (ADL) and instrumental ADL by the Barthel index and the Seoul-Instrumental Activities of Daily Living (S-IADL) scales, respectively. Depressive symptoms were assessed using the 15-item Geriatric Depression Scale (GDS-15). The EPS group was defined by the presence of at least 1 EPS based on a focused neurologic examination.
Results:
The prevalence of EPS-positive patients was 12%. These had lower Korean version of the Mini-Mental State Examination (K-MMSE) scores than the EPS-negative cases (P < .001). After controlling for demographic, medical, radiological, genetic, and cognitive (K-MMSE) factors, the proportion of patients with impaired ADL was significantly higher in the EPS group than in the non-EPS group (P < .001, odds ratio = 1.90, 95% confidence interval, 1.45–2.48, and logistic regression). The S-IADL scores were significantly higher in the EPS group than this in the non-EPS group (P < .001, regression coefficient = 3.19, and median regression). The GDS-15 scores were higher in the EPS group (P = .04, regression coefficient = 0.89, and median regression).
Conclusion:
The presence of EPS in patients with AD who were not receiving neuroleptic drugs was associated with more impaired basic and instrumental ADL functioning and with greater depression symptoms.
GalaskoDKwo-on-YuenPFKlauberMRThalLJ.Neurological findings in Alzheimer's disease and normal aging. Arch Neurol. 1990;47(6):625–627.
2.
ChenJYSternYSanoMMayeuxR. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol. 1991;48(11):1141–1143.
3.
MayeuxRSternYSpantonS. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology. 1985;35(4):453–461.
4.
MerelloMSabeLTesonAExtrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1994;57(12):1503–1509.
5.
ChuiHCLynessSASobelESchneiderLS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol. 1994;51(7):676–681.
6.
SternYAlbertMBrandtJUtility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 1994;44(12):2300–2307.
7.
LopezOLWisnieskiSRBeckerJTBollerFDeKoskyST. Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol. 1997;54(8):969–975.
8.
ScarmeasNAlbertMBrandtJMotor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64(10):1696–1703.
9.
SamsonWNvan DuijnCMHopWCHofmanA. Clinical features and mortality in patients with early-onset Alzheimer's disease. Eur Neurol. 1996;36(2):103–106.
10.
PotkinSG.The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients. Int Psychogeriatr. 2002;14(suppl 1):7–26.
11.
AndersenCKWittrup-JensenKULolkAAndersonKKragh-SorensenP. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004;2:52.
12.
MortimerJAEbbittBJunSPFinchMD. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology. 1992;42(9):1689–1696.
13.
Coey-BloomJGalaskoDHofstetterCRJacksonJEThalLJ. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc. 1993;41(1):31–37.
14.
DrachmanDAO'DonnellBFLewRASwearerJM. The prognosis in Alzheimer's disease. ‘How far’ rather than ‘how fast' best predicts the course. Arch Neurol. 1990;47(8):851–856.
15.
MFMMolanoACastroJZarranzJJ. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment. Curr Alzheimer Res. 2010;7(6):517–526.
16.
CummingsJL. Depression and Parkinson's disease: a review. Am J Psychiatry. 1992;149(4):443–454.
17.
ReijndersJSEhrtUWeberWEAarslandDLeentjensAF.A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183–189; quiz 313.
18.
WeintraubDMobergPJDudaJEKatzIRSternMB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc. 2004;52(5):784–788.
19.
SchragAJahanshahiMQuinnN. What contributes to quality of life in patients with Parkinson's disease?J Neurol Neurosurg Psychiatry. 2000;69(3):308–312.
20.
ParkHKNaDLHanS-HClinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer's disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. J Korean Med Sci. 2011;26(9):1219–1226.
21.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944.
22.
PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985–1992.
23.
GibbWRLeesAJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–752.
24.
McKeithIGGalaskoDKosakaKConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113–1124.
25.
MoonSYNaDLSeoSWImpact of white matter changes on activities of daily living in mild to moderate dementia. Eur Neurol. 2011;65(4):223–230.
26.
MorrisJC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414.
27.
KangYWNaDLHahnS.A validity study on the Korean Mini-Mental State Examination in dementia patients. J Korean Neurol Assoc. 1997(15):300–307.
28.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
29.
MahoneyFIBarthelDW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65.
30.
AhnISKimJHKimSImpairment of instrumental activities of daily living in patients with mild cognitive impairment. Psychiatry Investig. 2009;6(3):180–184.
31.
KuHMKimJHKwonEJA Study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc. 2004(43):189–199.
32.
SheikhJIYesavageJABrooksJO 3rdProposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr. 1991;3(1):23–28.
33.
BaeJNChoMJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res. 2004;57(3):297–305.
34.
InzitariDSimoniMPracucciGRisk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med. 2007;167(1):81–88.
35.
BaeznerHBlahakCPoggesiAAssociation of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70(12):935–942.
36.
LyketsosCGSteeleCBakerLMajor and minor depression in Alzheimer's disease: prevalence and impactJ Neuropsychiatry Clin Neurosci. 1997;9(4):556–561.
37.
RappMASchnaider-BeeriMPurohitDPPerlDPHaroutunianVSanoM. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry. 2008;16(2):168–174.
38.
OlesenPJGustafsonDRSimoniMTemporal lobe atrophy and white matter lesions are related to major depression over 5 years in the elderly. Neuropsychopharmacology. 2010;35(13):2638–2645.
39.
LiebermanA. Depression in Parkinson's disease—a review. Acta Neurol Scand. 2006;113(1):1–8.
40.
EllisRJCaligiuriMGalaskoDThalLJ. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord. 1996;10(2):103–114.
41.
PortetFScarmeasNCosentinoSHelznerEPSternY. Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch Neurol. 2009;66(9):1120–1126.
